tradingkey.logo

Core Scientific's Q2 revenue misses estimates, net loss widens

ReutersAug 8, 2025 8:20 PM


Overview

  • Core Scientific fiscal Q2 2025 revenue misses analyst expectations, falling to $78.6 mln

  • Net loss widens to $936.8 mln, driven by non-cash fair value adjustments


Result Drivers

  • BITCOIN MINING DECLINE - 62% decrease in bitcoin mined led to lower digital asset self-mining revenue, partially offset by higher bitcoin prices

  • STRATEGIC SHIFT - Hosted mining revenue fell due to strategic focus on colocation services

  • COLOCATION EXPANSION - Revenue from colocation services increased due to expansion into Denton, Texas


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Miss

$78.60 mln

$81.60 mln (13 Analysts)

Q2 EPS

-$0.04

Q2 Adjusted EBITDA

$21.50 mln

Q2 Gross Profit

$5 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 9 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the blockchain & cryptocurrency peer group is "buy"

  • Wall Street's median 12-month price target for Core Scientific Inc is $18.00, about 20.3% above its August 7 closing price of $14.35

Press Release: ID:nBw9yNjwza

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI